COVID-19

Burnout problems persisted prior to the COVID-19 pandemic, but have been made worse since the beginning of the pandemic.

The FDA moved to shorten the time between the second and third vaccine dose from 6 months to 5 months for recipients of Pfizer-BioNTech.

GI symptoms manifest in children with COVID-19 more than they do in adult patients.

Allergists discuss the differing opinions of allergies and optimizing patient care during the COVID-19 pandemic.

Of the SCD patients who contracted COVID-19, 49% of them visited the Grady Comprehensive Sickle Cell center because of a vaso-occlusive event.

Patients with SCD were not at an increased risk of death or disease complications.

The data shows booster shots offer particularly strong protection against the variant.

Among vaccinated individuals, results show a 90% lower mortality rate due to COVID-19 in the group that received a booster compared with those who did not.

In a recent clinical trial, Evusheld recipients at increased risk of severe COVID-19 infection saw a 77% reduced risk of developing COVID-19.

Investigators detail the clinical criteria of the condition and speak to the safety of the COVID-19 vaccine for this patient population.

Promising results show that high-flow oxygen therapy is more effective in treating patients with severe COVID-19 than conventional methods like invasive mechanical ventilation.

Investigators found about 70% of rheumatology patients had a good antibody response to the COVID-19 vaccines.

Several different cardiovascular symptoms have presented in patients with COVID-19.

Authors suggest children with uncontrolled asthma should be considered for priority for COVID-19 vaccination.

Patients with history of VTE, peak D-dimer ≥3 μg/mL, and predischarge CRP ≥10 mg/dL were at high risk of experiencing new onset of VTE after hospital discharge.

Managers will face a number of challenges in the next year.

The overall risk of SARS-CoV-2 breakthrough infection was 15.4% in the multiple myeloma population and 3.9% in the noncancer population.

Among the 3 cohorts studied, patients with schizophrenia had the highest mortality rates from a COVID-19 infection.

Earlier today the FDA authorized booster doses for the Pfizer or Moderna vaccine for all adults.

Dr. Worobey suggested in his report that the vendor’s ties to the Huanan Seafood Wholesale Market strongly suggested the pandemic originated at the Wuhan market.

Investigators also noted that higher rates of infection were observed in Black patients.

Despite this, asthma severity was not associated with higher risk of COVID-19.

Patients who are treated with B cell depletion therapies show that their B cell count at time of vaccination can impact their COVID-19 antibody response.

Derek Jones talks about how the pandemic will shape healthcare in the coming years.

The FDA has yet to rule on twice-daily pill.

Incidence rates of post-Ad26.COV2.S vaccination cerebral venous sinus thrombosis was 8.65 per 100,000 person-years.

Hospital systems were able to effectively mitigate challenges during COVID-19, with 24-hour time-to-surgery benchmarks unchanged from before to after the pandemic.

Even though COVID-19 infection disproportionately impacts minority patients, there’s no indication that vaccine intention differs depending on race in IBD patients.

Though immunogenicity responses to the vaccine were lower in dialysis patients, the lower response rate was less apparent in second doses.

Hospitalized patients were more likely to have impairments in attention, executive functioning, and category fluency compared to those in the outpatient group.